First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule-Reference-Cited by-同舟云学术

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule

Published:2005-03 Issue:3 Volume:47 Page:405-412
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Quoix Elisabeth,Breton Jean-Luc,Ducoloné Alain,Mennecier Bertrand,Depierre Alain,Lemarié Etienne,Moro-Sibilot Denis,Germa Caroline,Neidhardt Anne-Catherine

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. The national cancer data base report on lung cancer;Fry;Cancer,1996

2. Underrepresentation of patients 65 years of age or older in cancer-treatment trials;Hutchins;N Engl J Med,1999

3. Participation of patients 65 years of age or older in cancer clinical trials;Lewis;J Clin Oncol,2003

4. Chemotherapy options for the elderly patient with advanced non-small cell lung cancer;Hennessy;Oncologist,2003

5. Non-small Cell Lung Cancer Collaborative Group (NSCLCCG). Chemotherapy in non-small cell lung cancer: a meta-analysis using up-dated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899–909.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crude polysaccharide from Danggui Buxue decoction enhanced the anti-tumor effect of gemcitabine by remodeling tumor-associated macrophages;International Journal of Biological Macromolecules;2023-07

2. A two‐stage phase II clinical trial design with nested criteria for early stopping and efficacy;Pharmaceutical Statistics;2019-09-10

3. Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study;Journal of Clinical Oncology;2016-05-01

4. A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD;PLOS ONE;2015-06-12

5. When less is better: the safety and efficacy of reduced intensity gemcitabine in a difficult patient population with advanced non-small-cell lung cancer;Medical Oncology;2013-01-16